Bladder Cancer 20 Year Survival Rates

Combination chemotherapy is now standard in the treatment of many cancers and has contributed to increasing survival and cure rates. The survival rate for the majority of patients with non-muscle invasive bladder cancer (NMIBC) is favorable; however, the rates of recurrence and progression to muscle-invasive bladder cancer (MIBC) are important surrogate endpoints for overall prognosis, as these are major determinants of long-term outcome. Risk Factors Although there are no direct causes of bladder cancer in both men and women, there are certain risk factors that tend to increase the chances of an individual developing bladder cancer. 23 Five-year and 10-year overall survival rates were 57% and 36%, respectively, with increased 5-year and 10-year disease-specific survival rates of 71% and. 1,2 In 2013, an estimated 7,900 Canadians will have been diagnosed with bladder cancer; however, the five-year survival rate for bladder cancer, overall, is about 80%. Most Common Types of Cancer The most common types of cancer throughout the country include breast, lung, prostate, colon, bladder, and skin. Alfred Witjes Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands 1. 2 days ago · Cancer increases with age, but also with smoking, drinking, pollution, bad diet, obesity, lack of exercise, and exposure to viruses. The clinical stage of the tumor (Figs. The period of time from exposure to development of cancer can be as long as 6-20 years. Most people who will get this cancer are older than 55, and risk increases with age. Molecular Markers. Cancer of the Bladder, Ureter, and Renal Pelvis. Because initial signs of urinary bladder cancer may be subtle, TCC is often quite invasive by the time it is clinically detectable and diagnosed. Bladder cancer survival rates are often used by physicians as points of reference when discussing patient outcomes. (3): Disease free survival for different lymph node status. Ten year survival rates have improved from around 21% in the mid 1970’s to approximately 60% for men diagnosed with prostate cancer between 1996 and 2000. In the 1980s, the cancer survival rate was less than 50%. 9%, while the comparative survival for all cancers combined rose to 68. market in 1999, and is prescribed to plow diabetes mellitus category 2.



Bladder cancer is more common as a person grows older. Five-year age-standardised net survival for bladder cancer in men has increased from 41% during 1971-1972 to 63% during 1990-1991 and then decreased to a predicted survival of 57% during 2010-2011 in England and Wales. Of the roughly 70,000 new cases annually, about 53,000 are in men. Treatment options Medical treatment. The overall 5-year survival rate after treatment with external beam radiation is 20-40%, compared with a 90% 5-year survival after cystectomy for organ-confined disease. Results of the BEACON. 2%, but the median cisplatine with a rate of 62. Cancer staging therefore helps the doctor to advise the patient about his condition and what forms of treatment are suitable, and to predict his survival rate in the next few years. More than three-quarters (85%) of the bladder cancer deaths were among people 65+ years old. BCG is a treatment with a bacteria instilled into the bladder that is effective in preventing or delaying recurrence of cancer in patients with this type of superficial bladder cancer. 5% at 2 years and 18. A large international cancer survival study called CONCORD-2 reported trends in five-year survival between 1995 and 2009 for close to 26 million cancer patients diagnosed with one of 10 common cancers: breast (women only), cervix, colon, leukemia, liver, lung, ovary, prostate, rectum, and stomach. Bladder cancer is less common among women (ranked twelfth) and accounts for 2. The median time to recurrence among those patients in whom the cancer recurred was 12 months (range, 0. The overall 10-year survival rate is 70% and the overall 15-year survival rate is 65%. The term survival rate is usually defined by considering the five year survival rate.



In recent decades there has been a steady increase in the incidence of bladder cancer. Combination chemotherapy is now standard in the treatment of many cancers and has contributed to increasing survival and cure rates. Phase IV bladder cancer has a relative 5-year survival rate of about 15%. The average duration of hospitalization was 18. Data from 702 patients with clinically localized bladder cancer from 2003 to date were analyzed for five-year recurrence-free survival (67%), cancer-specific survival (75%) and overall survival (50%). • Irritative voiding symptoms without UTI: • 20% - 30% of cases, 50% of cases without hematuria. 8) were 53-72% for males and 39-63% for females. Although many advances have been made in the management of. Bladder cancer is less common among women (ranked twelfth) and accounts for 2. For people diagnosed with bladder cancer in 2002-06, five-year relative survival rates (Fig. CT urogram. Source: (1) "Use of Hapten Combined Cytotoxic Drugs for Enhancing Therapeutic Effect in Advanced Stages of Pancreatic Cancer," Journal of Liver Research, Disorders & Therapy, December 30, 2015; (2) "Hapten Improved Overall Survival Benefit in Late Stages of Non-Small Cell Lung Cancer. While many patients are understandably interested in survival statistics, it must be emphasized that this information is based on past outcomes of bladder cancer patients with vastly different circumstances. • Highest for multifocal T1, G3 + CIS. Association of the Nordic Cancer.



PURPOSE: To evaluate the long-term oncological and functional results after prostate sparing cystectomy (PSC) for bladder cancer (BC). After 10 years, the survival rate is around 70% and after 15 years, the survival rate is. Of greater concern than recurrence is the risk of progression to muscle-invasive, locally-advanced, or metastatic bladder cancer. Diagnosed with bladder cancer in 2010, he'd undergone chemotherapy but the cancer spread to his brain. The 5-year relative survival rate for stage III bladder cancer has to do with 46%. Ten year survival rates have improved from around 21% in the mid 1970’s to approximately 60% for men diagnosed with prostate cancer between 1996 and 2000. Home > Cancer Types > Urinary > Bladder Cancer. Mak et al recently published a pooled analysis of long-term outcomes from six Radiation Therapy Oncology Group protocols of selective, bladder-preserving CMT which demonstrated a CR of 69%. 4% per year among women from 2006 to 2015; 1. Urinary bladder cancer can affect any site in the urinary tract. Muscle invasive bladder cancer is a highly aggressive disease, with a high rate of early metastatic dissemination, and a low 5-year overall survival rate. While bladder cancer is an extremely common cancer with a five year survival rate of only around 50 percent, it is mostly "unheard of" compared to other common cancers such as breast or prostate cancer which actually have a higher five year survival rate. Ten-year survival rates are 87% in well-differentiated liposarcoma, 76% in myxoid liposarcoma and 39% in pleomorphic liposarcoma. Treatment options Medical treatment. About half of bladder cancers are caught when the disease is confined to the inner lining of the bladder. But invasive transitional cell carcinoma or TCC is the most common type of canine urinary bladder cancer. The 5-year survival rate with a functioning bladder was 38%, 36% in arm 1 and 40% in arm 2.



2019-07-03T09:38:48+07:00 Syah Mirsya Warli war_uro@yahoo. The CR rate from TURBT and intravesical BCG is approximately 70%, however, a significant percentage of patients with high risk disease experience a recurrence and progression risk is 30-40% over a 10-year period. In this paper, we present a case of metastatic SCCB managed by chemotherapy and we would provide a brief review of the epidemiology, clinical features, diagnosis, pathologic features, staging, treatment, and prognosis of SCCB. Although many advances have been made in the management of. Ten year survival rates have improved from around 21% in the mid 1970’s to approximately 60% for men diagnosed with prostate cancer between 1996 and 2000. Read more about bladder cancer types, its symptoms, diagnosis, and treatment here. In 2012, there were 738 new cases of bladder cancer in Alberta accounting for 5% of the cancers diagnosed in Alberta. 2%, but the median cisplatine with a rate of 62. 9% of women. 2 It is estimated that about 20% of bladder cancer patients have this mutation. UC Davis researcher Dr. 5), Minnesota (475), and Iowa (470. 4% are diagnosed at the local stage and the 5-year survival for localized bladder cancer is 70. From 2010 to 2014, Western Australian data showed that the 5-year relative survival for bladder cancer had fallen to an all-time low of 53. Bladder cancer is the 4th most common in North America with five year survival rates of 40-80% (Appendix D). Cancer Survivor Rates The 10-year survival rate for bladder cancer is approximately 50%. African-American women, particularly have poor outcomes when diagnosed with bladder cancer. While early-stage bladder cancer has a high survival rate, disseminated late-stage bladder cancer has a 5-year survival rate of 5 percent. Cancer survival rate in India among the lowest in the world.



Immune drug for deadly skin cancer shows long-term survival. Small cell carcinoma of the bladder (SCCB) is rare, highly aggressive and diagnosed mainly at advanced stages. The ability of HAL cystoscopy to identify more bladder tumors does lead to a 20%-30% lower recurrence rate following TUR for Ta tumors. Those living in New Mexico along the U. Bladder cancer survival rates are often used by physicians as points of reference when discussing patient outcomes. survival, as well as local and distant recurrence in patients with node-negative bladder cancer at the time of cystectomy. As you come to terms with life after your initial treatment or surgery, you will find that doctors do not always ask about quality-of-life issues. 001) or ureterectomy (85. Prostate Sparing Cystectomy for Bladder Cancer: 20-Year Single Center Experience Author links open overlay panel Laura S. Muscle invasive carcinoma carries a 5-year survival rate of 20% to 50%. With dwindling options, the 51-year-old found a trial of a new immunotherapy drug called. Occult metastases are thus most lik. [1] It is estimated that nearly 300,000 people are walking around right now with bladder cancer in a variety of stages. Population counts for denominators are based on Census populations as modified by NCI. The bladder preservation rates were 58.



The period of time from exposure to development of cancer can be as long as 6-20 years. Nevertheless, external beam radiation therapy is used in various countries other than the United States for T2-T3 urothelial carcinoma of the bladder. Bladder cancer recurred in 311 patients (30%). 7 months versus 15. This year, almost 71,000 Americans will be diagnosed with bladder cancer. Bladder cancer is the fourth most common malignancy in men and the eighth most common in women. Risk Factors Although there are no direct causes of bladder cancer in both men and women, there are certain risk factors that tend to increase the chances of an individual developing bladder cancer. Simple changes in diet and lifestyle may quadruple breast cancer survival. The five-year survival rate is 76 per cent in the US, and 68 per cent in Europe, but survival tends to be better in higher-income than lower-income countries. According to the American Cancer Society, the relative survival rates for all stages of bladder cancer are: 5 years: 77 percent; 10 years: 70 percent; 15 years: 65 percent. For stage II bladder cancer, the 5-year relative survival rate is about 63%. Most Common Types of Cancer The most common types of cancer throughout the country include breast, lung, prostate, colon, bladder, and skin. Local recurrence was observed in 6 patients and liver metastasis in 2 patients. Because initial signs of urinary bladder cancer may be subtle, TCC is often quite invasive by the time it is clinically detectable and diagnosed. A study by Herr35 of 162 patients with lymph node–positive bladder cancer showed 5-year disease-specific survival of 5% for LNDt greater than 20% and 60% for LNDt less than or equal to 20%. ABSTRACT: Bladder cancer is the most common urologic malignancy and is expected to affect approximately 54,000 people in 1998. Of greater concern than recurrence is the risk of progression to muscle-invasive, locally-advanced, or metastatic bladder cancer.



Bladder Cancer Treatment at Top Cancer Hospitals in India - Bladder cancer typically begins in the lining of your bladder,the balloon-shaped organ in your pelvic area that stores urine. 2-4 Although surgery is considered the standard. The survival rate following bladder cancer treatment can vary based on the stage of the disease at the time of diagnosis. By definition, bladder cancer is the type of cancer in your urinary bladed affecting more than 70,000 lives in the US. Bladder cancer is the second most common genitourinary malignant disease in the USA, with an expected 69 000 newly diagnosed cases in 2008, and 14 000 deaths. The five year survival rate, on average, is about 76. Randomized trials show that a 3 to 4-month delay in surgery is not detrimental to overall outcome and survival is improved in all clinical stages of muscle invasive bladder. 5), Louisiana (477. The racial differences are significant in a multivariate Cox regression. David McConkey, PhD, Director of the. None of these differences are statistically significant. 75–80% of cases are Non-Muscle-Invasive Bladder Cancer (NMIBC), with the remaining Muscle- Invasive Bladder Cancer (MIBC) [2]. 0% in this study also compared reasonably to most upfront CCRT trials. In women, bladder cancer is the eighth most common cancer and the 10th cause of cancer death. Bladder cancer is a disease that is sensible to chemotherapy but is and survival at 2 years of 36. Researchers hope to. If the diagnosis and treatment of the disease are delayed, the survival rate can drop as low as 15 percent.



High Risk Bladder Cancer. 8%) and blacks have the worst (52. This is an increase of 19. In 2015 it resulted in 188,000 deaths. Micropapillary Bladder Cancer: I Have It, Now What Does it Mean? More than 75k people in the United States are diagnosed with bladder cancer on an annual basis and its estimated that >500k people in the US are living with the disease. The rate of BC diagnosis in men is 4 times greater than in women and the 5-year survival rate varies from 40-80% Ranasinghe et al. Australia’s high rates of bladder cancer deaths show why blood in urine should always be investigated October 19, 2017 3. Learn more about the facts and statistics associated with bladder cancer, including age, survival rates, recurrence rates and more with American Bladder Cancer Society. The prognosis depends on whether the cancer is localized, regional, or metastatic at the time of diagnosis. In this paper, we present a case of metastatic SCCB managed by chemotherapy and we would provide a brief review of the epidemiology, clinical features, diagnosis, pathologic features, staging, treatment, and prognosis of SCCB. Alfred Witjes Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands 1. The cancer is high grade and has grown into the wall of the pelvis. 9 per cent, while 51. In 2014, 74,690 bladder cancer patients were diagnosed with a reported 78 percent five-year survival rate. Non-Hodgkin's Lymphoma. Below is the five-year survival rate for bladder cancer patients treated by SCCA compared to patients who were treated for bladder cancer elsewhere. In 2015, 2747 new cases of bladder cancer were diagnosed in Australia. Standard Treatment. For extensive SCLC disease, that is, cancer that has spread beyond half the chest, the average life-span in untreated patients is about 6 weeks.



However, survival rates depend on many factors, including the type and stage of bladder cancer that is diagnosed. About 40 percent of melanoma patients in the study were still alive three years later. 2%, respectively, in women. If the cancer spreads to the lymph nodes, the survival rate decreases dramatically, and about 33% of people will survive five years. One year survival from melanoma is 96. The overall 10-year survival rate is 98%, and the 15-year survival rate is 96%. Bladder cancer can be effectively treated if it is found early, before it spreads outside the bladder. Although the aforementioned seems grim, it may be comforting to know that survival rates are based upon research gathered from thousands of people and cannot predict any single outcome of cancer. Treatment options for this form of cancer include surgery, radiation, and chemotherapy. The chances of surviving bladder cancer for five years is 54%. Urothelial (transitional cell) carcinoma is the predominant histologic type in the United States and Europe, where it accounts for 90 percent of all bladder cancers. In fact, over two years, just 15 percent of men with low-risk prostate cancer went in for all of the recommend follow-ups. Four times more men than women tend to get this disease. Statistical survival rates for colorectal cancer help in developing new treatments for cancer and determining their effectiveness. The overall 5-year cancer-specific survival rate after cystectomy in our study population was only 20.



Bladder cancer survival rates are often used by physicians as points of reference when discussing patient outcomes. What is the prognosis for bladder cancer in cats and dogs? Survival is affected by the growth rate of the tumor, the exact location of the tumor within the bladder, and whether the tumor has spread to other organs or not. According to the American Cancer Society, the relative survival rates for all stages of bladder cancer are: 5 years: 77 percent; 10 years: 70 percent; 15 years: 65 percent. Bladder cancer is the second most common genitourinary malignant disease in the USA, with an expected 69 000 newly diagnosed cases in 2008, and 14 000 deaths. A study found a strain of the […] The common cold 'could cure bladder cancer' | Nexbie TV The common cold could one day be used to cure bladder cancer, research suggests. Source: (1) "Use of Hapten Combined Cytotoxic Drugs for Enhancing Therapeutic Effect in Advanced Stages of Pancreatic Cancer," Journal of Liver Research, Disorders & Therapy, December 30, 2015; (2) "Hapten Improved Overall Survival Benefit in Late Stages of Non-Small Cell Lung Cancer. Patients with superficial tumours have an excellent prognosis with five-year survival rates between 80-90%. Urothelial (transitional cell) carcinoma is the predominant histologic type in the United States and Europe, where it accounts for 90 percent of all bladder cancers. The overall 5-yearand lO-year survival rates were 90% and 86%, respectively. on stage 3 bladder cancer life expectancy: Without treatment the cancer will continue to spread. 9 million per year in 2020, although the rate of people who get cancer is expected to stay about the same. Immune drug for deadly skin cancer shows long-term survival. Studies (1980) showed that people who use artificial sweeteners do not appear to have a higher incidence of bladder cancer than that of non-users. 5%, and the mortality rate is 2. Blood Cancer Survival Rates- Lymphoma. Cancer of the Bladder, Ureter, and Renal Pelvis. Urinary Bladder Cancer • 5 y Survival rate for metastatic disease 5% 5-year survival after cystectomy. Defense Department to study a novel way. Doctor answers on Symptoms, Diagnosis, Treatment, and More: Dr. If the bladder cancer has infected the local lymph nodes, the 5-year survival rate for stage IV is 34 percent.



Bladder cancer is more common in males than females. Overall, the survival rate for prostate cancer 10 years after diagnosis is 98 percent. Wardha has the highest incidence of mouth cancer in the world. 4%, adjusted for increase in total world population. When diagnosed and treated early, bladder cancer has a relative five-year survival rate of 95 percent. Treatment relies upon the phase of the cancer. 4 Bladder cancer is also the fourth and eighth most common malignancy in men and women, respectively, and the number of diagnosed cases is increasing annually. Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. sive bladder cancer. For these cancers, the 5-year survival rate is 29%. A colonoscopy is the most effective test to diagnose colon. The origin of the disease is unknown; however the multipotent stem cell theory applies best to this case. Despite the clear survival advantage, population-based studies show that only approximately 20% of muscle-invasive bladder cancer patients receive neoadjuvant chemotherapy, while AC is reportedly. The 3-year survival was reported. The overall survival rate was 37. bladder cancer has a very good survival rate. In the 1980s, the cancer survival rate was less than 50%. Each year more than 70,000 Americans are diagnosed with bladder cancer and the number continues to increase. 4 This means that on average, 98 out of 100 people diagnosed with stage 0 bladder cancer are alive five years after being diagnosed. 9%, while the comparative survival for all cancers combined rose to 68.



, Global Clinical Research Lead, Oncology, Bristol-Myers Squibb, commented, "We are excited to present for the first time results for Opdivo in previously treated metastatic urothelial cancer, a type of bladder cancer. Almost 71,000 new cases of bladder cancer are diagnosed in the U. But the doctors are still doing research on solutions and treatments for future use. Males are more often affected than females. Including 18 patients with muscle invasive bladder tumor, overall survival rate was 80% for T2a tumors, whereas it was only 8% for T2b tumors (3). Five year survival rate varies by stage at diagnosis. In particular, early-phase trials of antibodies that interfere with the T cell checkpoint molecule PD-1 have shown clinical activity in tumor types as diverse as melanoma, lung cancer, bladder cancer, stomach cancer, renal cell cancer, head and neck cancer, and Hodgkin’s lymphoma. For stage IV ovarian cancer, the 5-year survival rate is 17. Five-Year Survival. Sep 14, 2016 · The survival rate for early-stage prostate cancer is 99 percent after 10 years, regardless of whether men undergo surgery, radiation or are "actively monitored," according to studies published. 4% per year among children ages 0-19 from 2011 to 2015. The survival rate following bladder cancer treatment can vary based on the stage of the disease at the time of diagnosis. predict subsequent disease progression in early stage bladder cancer. UC Davis researcher Dr. 5%, and the mortality rate is 2. The general 5-year survival rate for people with bladder cancer is 77%. The 3-year survival was reported. *Scroll on Mobile Devices to See Full Results. The actuarial 5 and 10-year overall survival and disease-specific survival rates for all 190 entered patients and for some clinically important sub-groups are shown in Table I.



In contemporary series, specific survival rates are about 60 to 65% at 5 years, decreasing for locally advanced disease to 45-50% in patients with nonorgan-confined lymph. There is an urgent need for highly sensitive and specific molecular markers that: identify bladder tumor recurrences in plasma or urine. If diagnosed in Stage 1, the 5-year survival rate for bladder cancer is 88%. Five-year survival rate: 17. percentage of bladder cancer diagnosed at an early stage has increased by 13% since 1981. Approximately 850 new cases of bladder cancer (24 cases per 100,000 people) are diagnosed in the state of Oregon each year. Prostate Sparing Cystectomy for Bladder Cancer: 20-Year Single Center Experience Author links open overlay panel Laura S. According to a report published by the National Cancer Institute, the survival rate for women with bladder cancer lags behind that of men at all stages of the disease. The five year survival rate, on average, is about 76. The five-year survival rate for patients with advanced melanoma who got other treatments was 16. The postoperative mortality and morbidity rates were 5. In this paper, we present a case of metastatic SCCB managed by chemotherapy and we would provide a brief review of the epidemiology, clinical features, diagnosis, pathologic features, staging, treatment, and prognosis of SCCB. Bladder cancer is less common among women (ranked twelfth) and accounts for 2. In another study of 90 patients with upper tract TCC managed endoscopically who had a history of bladder cancer, the recurrence-free survival rate at 5 years was only 29%. Although many advances have been made in the management of. This is an increase of 19. About four times more men get bladder cancer than do women. Survival rates for colorectal cancer are remarkably individual, even when it has spread and a patient is at an advanced stage of cancer. The 5-year survival rate for patients with stage 0 bladder cancer was 66% at 5 years and 59% at 10 years, and the rate of overall survival was 57% More than 20% of all patients with. Androgen Deprivation Therapy: Although Clinical studies have demonstrated that ADT combined with EBRT delays cancer progression and improves survival in men with stage III prostate cancer, the optimal timing and duration of ADT is still being evaluated in clinical trials as is the role of ADT following prostatectomy in high risk patients.



Five-Year Survival Rates (from the National Cancer Institute's Physician Data Query system, July, 2002) Prognosis and survival correlate with cell type: clear cell tumors have the best prognosis. 3 Bladder cancer accounts. This number steadily drops with cancer stage progression. Bladder cancer can be effectively treated if it is found early, before it spreads outside the bladder. This article introduces the basic knowledge of stage 4 cancer and its survival rate. This is a single-arm, multicenter, Phase 2 study to evaluate the efficacy and safety of the anti- programmed cell death-1(PD-1) monoclonal antibody BGB-A317 in participants with PD-L1+, locally advanced or metastatic UBC who have progressed during or following a platinum-containing regimen. However, the five year progression and re-. Bladder cancer is more common as a person grows older. Using statistical models for analysis, rates for new bladder cancer cases have been falling on average 1. Doctor answers on Symptoms, Diagnosis, Treatment, and More: Dr. These data are being used by states to effectively develop comprehensive cancer control. This means that with treatment you have a 15 percent chance of surviving for 5 years after a diagnosis of stage 4 bladder cancer. More than three-quarters (85%) of the bladder cancer deaths were among people 65+ years old. This rate is almost 20 percent higher than the U. Prostate Sparing Cystectomy for Bladder Cancer: 20-Year Single Center Experience Author links open overlay panel Laura S.



Treatment relies upon the phase of the cancer. 4% Lifetime risk: 1 in 14 for men, 1 in 17 for women While breast and prostate cancers are more common, lung cancer is, according to the ACS, "by far" the leading cause. if the cancer is discovered early than the survival rate or five years is 94%. The worldwide incidence of bladder cancer in men was around 4. Presently, since the 2002 version did not include any changes for the staging of bladder cancer, the use of the 1997 version is still encouraged in most guidelines. This means that with treatment you have a 15 percent chance of surviving for 5 years after a diagnosis of stage 4 bladder cancer. • The 5-year relative survival rate for Stage III bladder cancer is about 46 percent. If the cancer spreads to the lymph nodes, the survival rate decreases dramatically, and about 33% of people will survive five years. The stage of development of the disease determines treatment options as well as patient age and health. The average five-year survival rate for people diagnosed with stage 0 bladder cancer is around 98% in the United States. ABSTRACT: Urothelial carcinoma, which is the most common type of bladder cancer, can affect the bladder, ureter, or renal pelvis. -Mexico border have even higher cancer mortality rates, with an average five-year cancer survival rate of 55. The overall 10-year survival rate is 98%, and the 15-year survival rate is 96%. EOquin® (Apaziquone) is the first new drug to be used for bladder cancer in more than 20 years and is a derivative of the commonly used Mitomycin C (MMC). 1% in WP-CCRT and BO-CCRT, respectively (p = 0. Incidence rates in the UK more than double for patients over 80 years of age compared to those patients under 70 (2, 3), and over the last 15-20 years there has been a significant increase in the proportion of patients presenting at age 80 years and over, from. The 5-year relative survival rate for stage III bladder cancer has to do with 46%. Bladder Cancer 20 Year Survival Rates.